APLS logo

Apellis Pharmaceuticals (APLS) Selling, general & administrative expenses

annual SGA:

$501.05M+$238.00K(+0.05%)
December 31, 2024

Summary

  • As of today (July 1, 2025), APLS annual SGA is $501.05 million, with the most recent change of +$238.00 thousand (+0.05%) on December 31, 2024.
  • During the last 3 years, APLS annual SGA has risen by +$324.28 million (+183.45%).
  • APLS annual SGA is now at all-time high.

Performance

APLS SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

quarterly SGA:

$129.34M+$7.86M(+6.47%)
March 31, 2025

Summary

  • As of today (July 1, 2025), APLS quarterly SGA is $129.34 million, with the most recent change of +$7.86 million (+6.47%) on March 31, 2025.
  • Over the past year, APLS quarterly SGA has dropped by -$160.00 thousand (-0.12%).
  • APLS quarterly SGA is now -11.19% below its all-time high of $145.65 million, reached on September 30, 2023.

Performance

APLS quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

TTM SGA:

-$12.10B-$223.68M(-1.88%)
March 31, 2025

Summary

  • As of today (July 1, 2025), APLS TTM SGA is -$12.10 billion, with the most recent change of -$223.68 million (-1.88%) on March 31, 2025.
  • Over the past year, APLS TTM SGA has dropped by -$12.63 billion (-2391.35%).
  • APLS TTM SGA is now -49067.40% below its all-time high of -$24.62 million.

Performance

APLS TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAPLSincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

APLS Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+0.1%-0.1%-2391.3%
3 y3 years+183.4%+152.7%-6559.4%
5 y5 years+647.3%+338.4%-10000.0%

APLS Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+183.4%-11.2%+104.7%-75.1%at low
5 y5-yearat high+647.3%-11.2%+355.2%-353.5%at low
alltimeall timeat high>+9999.0%-11.2%>+9999.0%<-9999.0%at low

APLS Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Mar 2025
-
$129.34M(+6.5%)
$500.89M(-0.0%)
Dec 2024
$501.05M(+0.0%)
$121.48M(-0.4%)
$501.05M(-3.9%)
Sep 2024
-
$121.98M(-4.8%)
$521.27M(-4.3%)
Jun 2024
-
$128.08M(-1.1%)
$544.93M(+3.2%)
Mar 2024
-
$129.50M(-8.6%)
$528.23M(+5.5%)
Dec 2023
$500.81M(+80.7%)
$141.70M(-2.7%)
$500.81M(+12.9%)
Sep 2023
-
$145.65M(+30.8%)
$443.48M(+17.9%)
Jun 2023
-
$111.37M(+9.1%)
$376.24M(+14.7%)
Mar 2023
-
$102.09M(+21.0%)
$328.07M(+18.4%)
Dec 2022
$277.16M(+56.8%)
$84.37M(+7.6%)
$277.16M(+18.3%)
Sep 2022
-
$78.41M(+24.1%)
$234.26M(+16.2%)
Jun 2022
-
$63.20M(+23.5%)
$201.62M(+7.6%)
Mar 2022
-
$51.19M(+23.5%)
$187.38M(+6.0%)
Dec 2021
$176.77M(+26.8%)
$41.46M(-9.4%)
$176.77M(-1.7%)
Sep 2021
-
$45.76M(-6.5%)
$179.80M(+5.1%)
Jun 2021
-
$48.97M(+20.7%)
$171.03M(+13.7%)
Mar 2021
-
$40.58M(-8.8%)
$150.48M(+7.9%)
Dec 2020
$139.40M
$44.49M(+20.3%)
$139.40M(+13.9%)
Sep 2020
-
$36.99M(+30.2%)
$122.38M(+17.7%)
Jun 2020
-
$28.41M(-3.7%)
$104.02M(+17.7%)
DateAnnualQuarterlyTTM
Mar 2020
-
$29.50M(+7.4%)
$88.38M(+31.8%)
Dec 2019
$67.05M(+196.2%)
$27.47M(+47.4%)
$67.05M(+45.9%)
Sep 2019
-
$18.63M(+45.8%)
$45.97M(+36.8%)
Jun 2019
-
$12.78M(+56.4%)
$33.60M(+25.5%)
Mar 2019
-
$8.17M(+27.9%)
$26.77M(+18.3%)
Dec 2018
$22.64M(+116.4%)
$6.39M(+2.0%)
$22.64M(+7.3%)
Sep 2018
-
$6.27M(+5.3%)
$21.11M(+24.8%)
Jun 2018
-
$5.95M(+47.4%)
$16.91M(+33.4%)
Mar 2018
-
$4.04M(-17.0%)
$12.68M(+21.2%)
Dec 2017
$10.46M(+143.1%)
$4.86M(+134.6%)
$10.46M(+56.4%)
Sep 2017
-
$2.07M(+21.1%)
$6.69M(+19.1%)
Jun 2017
-
$1.71M(-6.1%)
$5.62M(+43.8%)
Mar 2017
-
$1.82M(+67.5%)
$3.91M(+87.3%)
Dec 2016
$4.30M(-32.3%)
$1.09M(+8.7%)
$2.09M(-48.4%)
Sep 2016
-
$1.00M(-67.1%)
$4.04M(-9.3%)
Dec 2015
$6.36M(+118.6%)
$3.04M(+115.3%)
$4.46M(+82.7%)
Sep 2015
-
$1.41M(+37.8%)
$2.44M(+43.8%)
Dec 2014
$2.91M(+70.5%)
$1.03M(+53.1%)
$1.70M(+153.1%)
Sep 2014
-
$669.70K
$669.70K
Dec 2013
$1.71M
-
-

FAQ

  • What is Apellis Pharmaceuticals annual SGA?
  • What is the all time high annual SGA for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals annual SGA year-on-year change?
  • What is Apellis Pharmaceuticals quarterly SGA?
  • What is the all time high quarterly SGA for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals quarterly SGA year-on-year change?
  • What is Apellis Pharmaceuticals TTM SGA?
  • What is the all time high TTM SGA for Apellis Pharmaceuticals?
  • What is Apellis Pharmaceuticals TTM SGA year-on-year change?

What is Apellis Pharmaceuticals annual SGA?

The current annual SGA of APLS is $501.05M

What is the all time high annual SGA for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high annual SGA is $501.05M

What is Apellis Pharmaceuticals annual SGA year-on-year change?

Over the past year, APLS annual SGA has changed by +$238.00K (+0.05%)

What is Apellis Pharmaceuticals quarterly SGA?

The current quarterly SGA of APLS is $129.34M

What is the all time high quarterly SGA for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high quarterly SGA is $145.65M

What is Apellis Pharmaceuticals quarterly SGA year-on-year change?

Over the past year, APLS quarterly SGA has changed by -$160.00K (-0.12%)

What is Apellis Pharmaceuticals TTM SGA?

The current TTM SGA of APLS is -$12.10B

What is the all time high TTM SGA for Apellis Pharmaceuticals?

Apellis Pharmaceuticals all-time high TTM SGA is -$24.62M

What is Apellis Pharmaceuticals TTM SGA year-on-year change?

Over the past year, APLS TTM SGA has changed by -$12.63B (-2391.35%)
On this page